Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Debt to Equity (2023 - 2025)

Utah Medical Products (UTMD) has 8 years of Debt to Equity data on record, last reported at $0.0 in Q3 2025.

  • For Q3 2025, Debt to Equity changed N/A year-over-year to $0.0; the TTM value through Sep 2025 reached $0.0, changed N/A, while the annual FY2024 figure was $0.0, 4.46% up from the prior year.
  • Debt to Equity reached $0.0 in Q3 2025 per UTMD's latest filing, down from $0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.0 in Q4 2024 and bottomed at $0.0 in Q3 2025.
  • Average Debt to Equity over 3 years is $0.0, with a median of $0.0 recorded in 2023.
  • The widest YoY moves for Debt to Equity: up 4.46% in 2024, down 4.46% in 2024.
  • A 3-year view of Debt to Equity shows it stood at $0.0 in 2023, then increased by 4.46% to $0.0 in 2024, then dropped by 15.14% to $0.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Debt to Equity were $0.0 in Q3 2025, $0.0 in Q1 2025, and $0.0 in Q4 2024.